342 related articles for article (PubMed ID: 16336609)
1. Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma.
Chaves P; Cruz C; Dias Pereira A; Suspiro A; de Almeida JC; Leitão CN; Soares J
Dis Esophagus; 2005; 18(6):383-7. PubMed ID: 16336609
[TBL] [Abstract][Full Text] [Related]
2. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation.
Chaves P; Cardoso P; de Almeida JC; Pereira AD; Leitao CN; Soares J
Hum Pathol; 1999 Nov; 30(11):1291-5. PubMed ID: 10571507
[TBL] [Abstract][Full Text] [Related]
3. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
4. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved.
Chaves P; Crespo M; Ribeiro C; Laranjeira C; Pereira AD; Suspiro A; Cardoso P; Leitão CN; Soares J
Mod Pathol; 2007 Jul; 20(7):788-96. PubMed ID: 17529926
[TBL] [Abstract][Full Text] [Related]
6. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
7. Enterocytic columnar non-goblet cells of Barrett's esophagus--an immunohistochemical demonstration of association with malignant evolution.
Chaves P; Cruz C; Cardoso P; Suspiro A; Pereira AD; de Almeida JC; Leitão CN; Soares J
J Exp Clin Cancer Res; 2003 Jun; 22(2):273-8. PubMed ID: 12866578
[TBL] [Abstract][Full Text] [Related]
8. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach.
Glickman JN; Shahsafaei A; Odze RD
Am J Surg Pathol; 2003 Oct; 27(10):1357-65. PubMed ID: 14508397
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
Vernygorodskyi S
Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
[TBL] [Abstract][Full Text] [Related]
10. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
[TBL] [Abstract][Full Text] [Related]
11. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus.
Bansal A; McGregor DH; Anand O; Singh M; Rao D; Cherian R; Wani SB; Rastogi A; Singh V; House J; Jones PG; Sharma P
Dis Esophagus; 2014; 27(8):751-6. PubMed ID: 24165297
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
13. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
14. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of metaplastic non-goblet columnar lined oesophagus shows phenotypic similarities to Barrett's oesophagus: a study in an Asian population.
Srivastava S; Liew MS; McKeon F; Xian W; Yeoh KG; Ho KY; Teh M
Dig Liver Dis; 2014 Feb; 46(2):170-5. PubMed ID: 24290871
[TBL] [Abstract][Full Text] [Related]
16. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
17. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
18. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
[TBL] [Abstract][Full Text] [Related]
19. Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus.
Hahn HP; Blount PL; Ayub K; Das KM; Souza R; Spechler S; Odze RD
Am J Surg Pathol; 2009 Jul; 33(7):1006-15. PubMed ID: 19363439
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical mucin expression of short-segment Barrett's esophagus.
Yamamoto S; Kijima H; Hara T; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Tokai J Exp Clin Med; 2003 Jul; 28(2):57-63. PubMed ID: 14714830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]